Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic and orthopedic markets. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic or orthopedic industry newsletters.
Recently Added
Murray Takes Over Centinel Spine CEO Position After Viscogliosi
Centinel Spine’s new CEO, Steven Murray, comes from his role as President of Advanced Sterilization Products and Johnson & Johnson; he was previously the president of Synthes Spine. John Viscoglios...
Study Indicates That Dual-Mobility Hip Implants Used for Revision May Have Fewer Complications
The Journal of Arthroplasty published a study comparing revisions of metal-on-metal THA using either a dual-mobility implant or complete revision of the acetabular component. Revisions were primari...
Zimmer Biomet Issues Field Safety Notice for Some StageOne and StageOne Select Molds
Zimmer Biomet announced March 17 that, due to potential insufficient cleaning and monitoring of StageOne and StageOne Select bone cement molds, it is issuing a field safety notice. Of 230 thousand ...
Acumed Enters Distribution Agreement With Vivorte
Acumed will become the exclusive distributer or Vivorte’s orthobiologics portfolio. The agreement, announced March 13, will give Vivorte access to Acumed’s sales, marketing, and medical education e...
Ortho RTI’s Rotator Cuff Tear Product Achieves Positive Results
Positive results from a preclinical study of Ortho Regenerative Technologies Inc.’s (Ortho RTI) rotator cuff tear repair product, Ortho-R, were announced March 12. The preclinical ovine work showed...
DePuy Synthes Receives CE Mark for Dual-Mobility Hip
DePuy Synthes received CE marking for its Bi-Mentum dual-mobility hip, the company announced March 12. The device is intended for patients at risk for dislocation to reduce the need for additional ...
Market Scope Lists 2020 Ophthalmic Meetings Canceled, Delayed Due to COVID-19
.jpg)
Market Scope is tracking the status of 2020 ophthalmic meetings worldwide as the COVID-19 outbreak spreads. Several conferences have been delayed or canceled outright. Here is the latest informatio...
COVID-19 Update: MDR Delay Coming?; Glaucoma Meeting Postponed; Companies Join Pandemic Fight
The European Commission (EC) is working on a proposal to delay enforcement of the EU Medical Device Regulation by a year, a spokesperson said March 25. Policymakers hope to submit the proposal in e...
Surgeon, LinkoCare Developing Corneal Inlay Made of Biosynthetic Collagen
Pavel Stodulka, MD, PhD, of the Czech Republic, is working with Swedish companyLinkoCare to develop a corneal reshaping inlay made of biosynthetic collagen to correct presbyopia. The inlay candidat...
Second Sight Gains CE Marking, US Conditional Approval for Wearables to be Tested with Orion
.png)
Second Sight announced March 19 that it had gained CE marking and US conditional approval for its next-generation wearables with the Argus II retinal prosthesis that include a more powerful video p...
Ribomic Licenses Wet AMD Candidate to Aju Pharm
.png)
Tokyo-based Ribomic reported March 17 that it had licensed to Aju Pharm a retinal candidate (RBM-007) for wet age-related macular degeneration (wet AMD) in Korea and Southeast Asia. Aju, of South K...
Iveric bio Appoints Dugel as Executive Vice President and Chief Strategy and Business Officer
Iveric bio announced March 23 that leading retina specialist Pravin Dugel, MD, would be appointed executive vice president and chief strategy and business officer, effective April 1. The New York c...
Past News Stories
McGuire Steps Down as CEO of Second Sight; Chairman Williams Takes Over as Interim Chief
Second Sight Medical Products CEO Will McGuire is leaving the company to accept a similar role at Ra Medical, a Carlsbad, California, medical device company focusing on commercializing excimer lase...
Lenstec Submits PMA Application to FDA for SBL-3 Segmented Bifocal Lens
.jpg)
Lenstec announced March 16 that had submitted a premarket approval application to the US FDA for its SBL-3 presbyopia-correcting intraocular lens (PC-IOL). The SBL-3 would be the first segmented bi...
Horama Licenses Retinal Gene Therapy Candidate from Leiden University
French ophthalmic gene therapy company Horama announced March 18 that it licensed from Leiden University Medical Center an adeno-associated viral (AAV) gene therapy program to treat inherited retin...
Graybug Ends Phase IIb Enrollment Early After Confirming Dosing Regimen
Graybug Vision announced March 18 that it had closed enrollment early in its Phase IIb trial of GB-102 (1 or 2 mg) in wet age-related macular degeneration (AMD), because the company intends to move...
Eyenovia Raises $5.3 Million in Private Placement for Microdose Candidates
Eyenovia reported March 25 that it raised $5.3 million in net proceeds in a private placement of units made up of common stock and warrants. The company said it intends to use the proceeds, togethe...
COVID-19 Update: OCTANe Summit, AAPOS Meeting, Industry Announcements
OCTANe has moved its Ophthalmology Technology Summit to July 31 from June 26 due to the pandemic, the group announced on its website. The Fashion Island Hotel in Newport Beach, California, remains ...
RSIP Vision Releases 3D Knee Reconstruction Technology That Uses Radiographs
RSIP Vision announced March 16 that its AI-based 3D reconstruction solution for knees is available. The technology takes pre-op X-rays and converts them into 3D anatomical models that can be used t...
CMS Proposes the Addition of Outpatient THA and TKA to Bundled Payment Plan
CMS published a proposed rule on March 5, suggesting that outpatient knee and hip replacement surgeries (TKA and THA, respectively) be added to the Comprehensive Care for Joint Replacement (CJR) Mo...
FDA Releases Third-Party Reviewer Guidelines
The FDA announced March 12 that it has released guidance for the 510(k) Third-Party Review Program, also known as 3P510k Review Program. Qualified third-party programs review premarket notification...
Study Shows Post-Traumatic Arthritis Has Larger Impact on TKA Complications Than OA
A study by Brockman et al., published in the Journal of Arthroplasty in Feb., compared TKA outcomes for 14,206 patients with post-traumatic arthritis and 1,287,188 patients with osteoarthritis (OA)...
Patients Will Have Access to Personal Health Data Under New HHS Rules
The HHS and CMS finalized two new rules, announced March 10, that will require providers to give secure, free access to health information for patients. Under the new rules, patients will be able t...
FDA Publishes Final Guidance for Bone Anchors
On March 7, the FDA released its final guidance for bone anchor 510(k) submissions. The guidelines include necessary submission requirements and recommended methods for bench testing. Specifically,...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.